南京医药：关于控股股东减持公司可转换公司债券的进展公告

Core Viewpoint - Nanjing Pharmaceutical announced a significant reduction in its convertible bonds by its controlling shareholder, indicating a strategic shift in investment or liquidity management [1] Group 1: Company Actions - The controlling shareholder, Nanjing New Industry Investment Group Co., Ltd., notified that it has reduced its holdings of "Nanjing Pharmaceutical Convertible Bonds" by 1,108,000 units [1] - This reduction represents 10.25% of the total issuance of the convertible bonds [1]